Publication | Closed Access

Trametinib plus 4-Methylumbelliferone Exhibits Antitumor Effects by ERK Blockade and CD44 Downregulation and Affects PD-1 and PD-L1 in Malignant Pleural Mesothelioma

Malignant Pleural MesotheliomaMedicineImmunologyPathologyImmune Checkpoint InhibitorErk BlockadeAffects Pd-1Anti-cancer AgentCancer TreatmentOncologyTumor MicroenvironmentTumor Biology